Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment

Glutamate, a crucial excitatory neurotransmitter, plays a major role in the modulation of schizophrenia’s pathogenesis. New drug developments for schizophrenia have been prompted by the hypoglutamatergic hypothesis of schizophrenia. The cystine/glutamate antiporter system x(c)(−) is related to gluta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chung-Chieh, Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466274/
https://www.ncbi.nlm.nih.gov/pubmed/34575878
http://dx.doi.org/10.3390/ijms22189718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466274/
https://www.ncbi.nlm.nih.gov/pubmed/34575878
http://dx.doi.org/10.3390/ijms22189718

Ejemplares similares